Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Clinical trial NCT04901702 · RECRUITING

Trial details

NCT number: NCT04901702
Sponsor: St. Jude Children's Research Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Solid Tumor Recurrent Ewing Sarcoma Recurrent Hepatoblastoma Recurrent Malignant Germ Cell Tumor Recurrent Malignant Solid Neoplasm Recurrent Neuroblastoma Recurrent Osteosarcoma Recurrent Peripheral Primitive Neuroectodermal Tumor Recurrent Rhabdoid Tumor Recurrent Rhabdomyosarcoma Recurrent Soft Tissue Sarcoma Recurrent Wilms Tumor

Start date: 2021-06-09
Primary completion: 2026-12-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.